What happens if the clinical trial treatment for Lung Cancer doesn't work

Lung CancerMay 15, 2026Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

What Happens If Lung Cancer Clinical Trial Treatment Doesn't Work?

This is an important question to ask before enrolling in any clinical trial. Let me explain what typically happens and what safeguards exist.

Your Rights and Options During a Trial

According to the NCCN Guidelines for Patients: Metastatic Non-Small Cell Lung Cancer, one of the key questions you should ask your care team before enrolling is: "Will I be able to get other treatment if this doesn't work?"

This is critical because:

  • You can leave at any time. The NCCN Guidelines emphasize that you can withdraw from a clinical trial and seek treatment outside the study at any point. This is your right.
  • You won't be abandoned. Your research team is required to continue monitoring your health and discussing next steps with you.
  • Standard care continues. Even while in a trial, you typically receive standard cancer care that's billed to your insurance, separate from the research treatment.

What Happens Medically

If the trial treatment isn't working, your care team will typically:

  1. Monitor your response - You'll get CT scans every 6 to 12 weeks to assess whether the cancer is shrinking, staying stable, or growing
  2. Discuss results with you - Your oncologist will explain what the scans show and what it means for your treatment
  3. Explore next options - According to NCCN Guidelines, if first-line therapy (initial treatment) isn't working, second-line therapy options exist, which may include:
    • Different immunotherapy checkpoint inhibitors
    • Chemotherapy drugs like docetaxel or gemcitabine
    • Combination approaches with drugs like ramucirumab
    • Other clinical trials that may be available

Questions to Ask Your Care Team

Before enrolling, specifically ask:

  1. "How will you know if the treatment is working?" (This helps you understand the monitoring plan)
  2. "What are the backup treatment options if this trial treatment doesn't work?"
  3. "Will I have access to other treatments while in the trial, or after I leave?"
  4. "How quickly can we switch to a different approach if needed?"
  5. "Are there other clinical trials I might be eligible for if this one doesn't work?"

The Reality of Clinical Trials

It's important to understand that according to NCCN Guidelines: "Despite advances in treatment, more research is needed. Current treatment rarely cures metastatic lung cancer or gives people a long life." This is why clinical trials exist—to develop better options.

The trial treatment might not work for you specifically, but:

  • The data you contribute helps researchers understand what works and what doesn't
  • You'll have access to a dedicated research team monitoring your care
  • You're not locked into the trial if it's not helping you
  • Standard treatment options remain available

Key Takeaway

You have agency and options. Clinical trials are voluntary, and your safety and access to effective treatment are protected. Don't hesitate to ask these questions upfront—good research teams expect and welcome them.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: